Vontier Corporation Common Stock VNT 深 滬
交易中 12-15 09:58:26 美东时间
37.04
-0.060
-0.16%
華盛通- 最 高37.43
- 今 開37.30
- 成交量 8056股
- 最 低 36.975
- 昨 收 37.10
- 總市值 53.71亿
- 52周最高 43.855
- 市盈率 靜 13.49
- 換手率 0.01%
- 52周最低 27.145
- 委 比 -85.63%
- 總股本 1.45亿
- 歷史最高 45.445
- 量 比 0.18
- 振 幅 1.23%
- 歷史最低 16.225
- 每 手 1
- 風險率 3.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多How Is The Market Feeling About Vontier Corp?
Vontier Corp's (NYSE:VNT) short interest as a percent of float has risen 40.08%...
11-29 04:00
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
B of A Securities Downgrades Vontier to Underperform, Lowers Price Target to $40
B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Underperform and lowers the price target from $50 to $40.
11-14 19:36
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
Keybanc Maintains Overweight on Vontier, Lowers Price Target to $45
Keybanc analyst Ken Newman maintains Vontier (NYSE:VNT) with a Overweight and lowers the price target from $50 to $45.
10-31 21:14
Vontier shares are trading lower after the company reported Q3 financial results and issued Q4 sales guidance below estimates. Also, the company narrowed its FY25 sales guidance below estimates.
Vontier shares are trading lower after the company reported Q3 financial result...
10-31 01:42
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Vontier Sees Q4 Adj EPS $0.82-$0.86 vs $0.86 Est; Sees Sales $760.000M-$770.000M vs $780.477M Est
Vontier (NYSE:VNT) is looking for Q4 Adj EPS of $0.82-$0.86 vs $0.86 analyst estimate. sees sales of $760.000 million-$770.000 million vs $780.477 million analyst estimate.
10-30 18:33
Vontier Q3 Adj. EPS $0.78 Beats $0.77 Estimate, Sales $753.000M Beat $747.898M Estimate
Vontier (NYSE:VNT) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.77 by 1.43 percent. This is a 6.85 percent increase over earnings of $0.73 per share from the same period
10-30 18:31
